Clinical Trials Directory

Trials / Completed

CompletedNCT05452382

Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma

Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma; a National Cancer Database Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
2,607 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

A few studies investigated the predictors of overall survival in appendiceal adenocarcinoma. A SEER database analysis of 1404 patients with appendiceal adenocarcinoma found that older age, T4 tumors, N1-2 stage, poorly differentiated carcinoma, and distant metastasis were significantly predictive of poorer survival. Another small single-center study including 49 appendiceal cancer patients reported female gender and low-grade adenocarcinoma to be associated with increased overall survival. However, these previous analyses did not take into account some important prognosticators of survival such as patients' comorbidities and functional status, pathologic parameters such as lymphovascular invasion, and adjuvant systemic treatment. Therefore, we used the National Cancer Database (NCDB) to conduct a comprehensive analysis of the predictors of overall survival after surgical treatment of stage I-III appendiceal adenocarcinoma.

Conditions

Interventions

TypeNameDescription
PROCEDUREPartial colecctomySegmental resection of appendiceal adenocarcinoma including terminal ileum and cecum
PROCEDUREHemicolectomyFormal right hemicolectomy including terminal ileum, cecum, and ascending colon

Timeline

Start date
2005-01-01
Primary completion
2019-12-30
Completion
2022-07-06
First posted
2022-07-11
Last updated
2022-07-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05452382. Inclusion in this directory is not an endorsement.